Tayanes, Gemma .
HRN: 28-80-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CLINDAMYCIN 300MG (CAP)
04/07/2026
04/14/2026
PO
1 Tab
BID
S/P Pelvic Lap
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: